DIRs are as much about patient access as it is about pharmacy business issues.
The partnership will give NPA members preferential access for their manufacturing facilities to become Informed-Choice Certified sites, NPA noted.
Its new identity will improve recognition that the generic and biosimilar medicines industry is one of “the nation's great health care success stories, and that competition from generics and biosimilars lowers the cost of medicine.”
ILI nationwide reached 4.8%, well above the national baseline of 2.2% and a sharp uptick in the 3.9% in ILI reported the week prior.
Noting that Price will play a key role in selecting the next commissioner for the Food and Drug Administration, the Consumer Healthcare Products Associaton offered several qualities that would embody an ideal candidate.
U.S. District Judge Josephine Staton for the Central District of California entered a consent decree of permanent injunction yesterday between the United States and VivaCeuticals, doing business as Regeneca Worldwide.
George Barrett is serving a two-year term at the nonpartisan group, an alliance of companies and organizations representing all sectors of American healthcare.
NACDS leadership also urges attendees to take part in RxIMPACT Day on Capitol Hill next month.
Nationwide during the week ended Jan. 28, 3.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness.
Already CRN has made significant progress in connecting to the 60 freshman Congressional leaders within the first 100 days, a promise CRN president and CEO Steve Mister shared with Drug Store News at the top of the year.